Schedules of Controlled Substances: Placement of Butonitazene, Flunitazene, and Metodesnitazene Substances in Schedule I

Document 2024-24635 is a Final Rule published by the Department of Justice in the Federal Register on October 25, 2024, with an effective date of October 25, 2024. The Drug Enforcement Administration places butonitazene, flunitazene, and metodesnitazene including their isomers, esters, ethers, salts and salts of isomers, esters and ethers in schedule I of the Controlled Substances Act. The regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess), or propose to handle these three specific controlled substances will continue to apply as a result of this action. View the original at https://www.federalregister.gov/documents/2024/10/25/2024-24635/schedules-of-controlled-substances-placement-of-butonitazene-flunitazene-and-metodesnitazene.

No. Document 2024-24635 is not classified as economically significant under Executive Order 12866. Economically significant rules require OIRA review and are estimated to have impacts of $100 million or more per year.